Aim: This paper reports on the incorporation of oleic acid (OA) within nanostructured lipid carriers (OA-NLC) to improve the anti-inflammatory effects in the presence of albumin. Materials and methods: NLCs produced via hot high-shear homogenization/ultrasonication were characterized in terms of particle size, zeta potential, and toxicity. We examined the effects of OA-NLC on neutrophil activities. Dermatologic therapeutic potential was also elucidated by using a murine model of leukotriene B4-induced skin inflammation. Results: In the presence of albumin, OA-NLC but not free OA inhibited superoxide generation and elastase release. Topical administration of OA-NLC alleviated neutrophil infiltration and severity of skin inflammation. Conclusion: OA incorporated within NLC can overcome the interference of albumin, which would undermine the anti-inflammatory effects of OA. OA-NLC has potential therapeutic effects in topical ointments.
Introduction
Fatty acids (FAs) are a major source of energy in mammalian bodies. They also have modulatory effects on immune responses and physiological functions. 1 FAs have been shown to stimulate or inhibit many inflammatory molecules (eg, reactive oxygen species (ROS), cytokines, and antibodies) and bioactive lipid mediators (eg, arachidonic acid (AA), linoleic acid (LA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA)). [1] [2] [3] [4] Oleic acid (OA; cis-9-octadecenoic acid), a monounsaturated omega-9 fatty acid (C18:1, n-9), is the most abundant fatty acid in healthy individuals, presenting in adipose tissue, plasma, and cell membranes. 5, 6 There is a growing body of evidence which indicates that OA is beneficial to blood pressure control and that it helps to slow the progress of cancer and inflammatory diseases. [7] [8] [9] [10] However, the role of OA in inflammatory responses remains controversial. Indeed, a number of studies have reported the anti-inflammatory of OA; 11 however, other studies have contradicted these claims. Nonetheless, most of the conflicting findings can be attributed to differences in methodology or OA concentration.
Ca 2+ mobilization through the modulation of plasma membrane Ca
2+
-ATPase. 12 However, higher concentrations of OA were required to suppress neutrophil effector functions in the presence of albumin. 12 This suggests that, to inhibit neutrophil activity, OA concentrations must exceed the FA binding capacity of albumin. The fact that FAs with long non-polar hydrocarbon chains are hydrophobic (ie, minimally water soluble) means that they must bind with albumin in order to be transported through vascular and interstitial compartments. However, it is possible that this binding may hampers the cellular effects of FA.
There is growing interest in the application of nanotechnology in the fields of molecular and cellular biology. Lipid-based nanoparticles have been developed as drug carriers with a range of therapeutic advantages, including enhanced drug stability and bioavailability, minimal systemic toxicity, prolonged circulation time, and improved biocompatibility. 13, 14 Nanostructured lipid carriers (NLC) are the latest generation of lipid nanoparticle drug carrier system. 15, 16 They are composed of mixtures of liquid and solid lipids that are biodegradable and biocompatible. Unlike solid lipid nanoparticles (SLNs), which have only a solid matrix, NLCs are characterized by the enhanced imperfections that result from the incorporation of liquid oil within the solid lipid core matrix. The imperfections increase the hydrophobic drug loading capacity and reduce the likelihood of drug expulsion. 15, 16 In a previous study, we reported that unsaturated FAs (USFAs) regulate the inflammatory responses of neutrophils but, in the presence of albumin, inhibitory effects were eliminated. In this current study, we adopted a wellestablished isolated human neutrophil model to test the hypothesis that incorporating OA within NLC (OA-NLC) could enhance its anti-neutrophilic inflammation functions in the presence of albumin. We also sought to elucidate the mechanism by which OA-NLC regulates neutrophil effector activity. We then examined the physicochemical properties of NLC, such as the size, and zeta potential, as well as the potential for toxicity. An animal model of leukotriene B4 (LTB4)-induced skin inflammation was used to evaluate the therapeutic effects of OA-NLC when delivered topically.
Materials and methods

NLC preparation
NLCs were produced via hot high-shear homogenization followed by ultrasonication in accordance with previously reported methods, albeit with minor modifications. 17 The lipid matrix, which consists of 6% palmityl palpitates, 1% soy phosphatidylcholine, and 6% OA, was heated up to 85°C to form a uniform oil phase. The aqueous solution, which contained the hydrophilic surfactant pluronic F68 (3.5%) and ddH 2 O (83.5%), was also heated to 85°C. Subsequently, the hot lipid matrix was gradually dispersed in the aqueous solution under the effects of high-shear homogenization (Pro250, Pro Scientific) at 12,000 rpm for 20 min. The resulting mixture was then ultrasonicated using a probe-type sonicator (VCX600, Sonics and Materials, Newtown, CT, USA) for 15 min duration at 35 W and 20 amplitudes without intermittent on/off cycle to obtain the final product.
Determining particle size and surface charge
The average particle size of the NLCs was determined via photon correlation spectroscopy, and surface charge (zeta potential) was measured via particle electrophoretic light scattering using a laser-scattering zetasizer (Nano ZS90, Malvern Instruments, Worcestershire, UK) at 25°C. The nanoparticles were diluted 100-fold with ddH 2 O before measurements. All measurements were repeated three times per sample.
Observation of morphology using transmission electron microscopy (TEM)
The shape and size of OA-NLC were visualized using a transmission electron microscope (Hitachi H-7500). For this, a drop of OA-NLC that had been diluted 100-fold with ddH 2 O was applied to a 200-mesh copper grid coated with formvar/carbon film (Agar Scientific, UK), and then subjected to negative staining with 1% phosphotungstic acid. The sample was subsequently dried in the air prior to observation under TEM.
Determination of OA entrapment efficiency (EE) in NLC
Entrapment efficiency was used to indicate the percentage of OA which is successfully entrapped into nanoparticles. It is calculated as follows:
The EE of OA was determined by first separating the OA from the NLC via ultracentrifugation at 48,000×g and 4°C for 40 min and then measuring the free OA in the supernatant using high-performance liquid chromatography. Because OA is short of significant chromophore, derivatization of OA with 2-bromoacetophenone was used to enhance its detectability. 18 Briefly, OA standard or OA separated from OA-NLC were dissolved in 0.5 mL acetonitrile, and then an excess amount of K 2 CO 3 powder was added. Subsequently, the derivatization procedure was started by adding 2-bromo-2-acetonaphthone (200 mg) and hexaoxacyclo octadecane (100 mg) in 20 mL acetonitrile to the sample, and then sonicated at 55°C for 1 h. Samples were analyzed by using a high performance liquid chromatography (HPLC) system, which includes a pump (PU-1580, Jasco), a sampler (AS-1555-10, Jasco), a UV detector (UV-1575, Jasco), and a 25-cm-long, 4.6-mm inner diameter C18 column (Supelco Analytical). The mobile phase consisted of ddH 2 O (7%) and methanol (93%) at a flow rate of 1 mL/min. The UV detector was set a wavelength of 250 nm.
Human neutrophil isolation
Human neutrophils were purified from peripheral venous blood within 3 h after collection from healthy volunteers. 19 All donors (aged 20-30 years) were informed of the risks associated with blood collection and provided written consent before blood was collected. All donors also declared that they did not have any systemic disease. Blood was layered on a density gradient using dextran sedimentation and Ficoll-Hypaque centrifugation. The neutrophil-rich layer was then collected, and contaminated red blood cells were disrupted via hypotonic lysis. Wright-Giemsa staining and trypan blue exclusion were respectively used to confirm the purity (≥99%) and viability (≥95%) of neutrophils. The isolated neutrophils were suspended in pH 7.4 Ca 2+ -free Hank's balanced salt solution (HBSS) with or without 0.1% bovine serum albumin (BSA) at 4°C prior to each experiment. This study was conducted in accordance with a protocol for human subjects that was approved by the institutional review board of Chang Gung Memorial Hospital.
Assessment of cytotoxicity
To assess the safety of the NLC formulations used in this study, the viability of NLC-treated neutrophils was determined by measuring the amount of lactate dehydrogenase (LDH) released from ruptured cells. LDH release was measured using a CytoTox 96 assay kit (Promega). Briefly, neutrophils (6×10 5 cells/mL) were first treated with various concentrations of OA or OA-NLC for 17 min. The cells were then centrifuged at 200 g at 4°C for 8 min, whereupon LDH assay reagents were added to the supernatant. Measured colorimetric signal were presented as a percentage of total LDH activity, as determined by measuring the fluorescence of lysed neutrophils treated with 0.1% Triton X-100.
Assessment of superoxide generation
Superoxide generation assays were conducted by measuring the reduction of ferricytochrome c. 19 For this, neutrophils (6×10 5 cells/mL) were suspended in HBSS that contained CaCl 2 (1 mM) and ferricytochrome c (0.5 mg/mL) at 37°C. The cells were then pretreated with vehicle, OA, or OA-NLC for 5 min, followed by the addition of cytochalasin B (1 μg/mL) for 3 min and then fMLF (0.1 μM) to activate the neutrophils. The reduction of ferricytochrome c was monitored by measuring changes in absorbance at 550 nm using a spectrophotometer (Hitachi U-3010, Tokyo, Japan). Control groups contained all the components of the assay buffer and additional superoxide dismutase (100 U/mL) for correction the ferricytochrome c reduction induced by agents other than superoxide.
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Luminol-enhanced chemiluminescence assay
Total ROS released from the neutrophils was evaluated by using the luminol-enhanced chemiluminescence method. Human neutrophils (2×10 6 cells/mL) were preincubated with luminol (37.5 μM) and horseradish peroxidase (6 U/ mL) at 37°C for 5 min. before being treated with vehicle, OA, or OA-NLC for 5 min. Cytochalasin B (0.5 μg/mL) and fMLF (0.1 μM) were then used to induce respiratory burst in neutrophils. Chemiluminescence was detected using a Tecan Infinite F200 Pro 96-well chemiluminometer (Tecan Group, Männedorf, Switzerland).
Elastase release
Upon activation, neutrophils release antimicrobial proteins in a process referred to as degranulation. Elastase release was measured spectrophotometrically using a synthetic elastase substrate, methoxysuccinyl-Ala-AlaPro-Val-p-nitroanilide. 19, 20 Human neutrophils suspensions (6×10 5 cells/mL) were preincubated in HBSS containing CaCl 2 (1 mM) and elastase substrate (0.1 mM) at 37°C. The cells were then treated with vehicle, OA, or OA-NLC (5-100 μM) for 5 min prior to stimulation with cytochalasin B (0.5 μg/mL) and fMLF (0.1 μM) or cytochalasin B (0.5 μg/mL) and LTB4 (0.1 μM). The extent of p-nitrophenol spectrophotometrically was continuously measured at 405 nm using a spectrometer (Hitachi U-3010).
Observation of NLC uptake by neutrophils
The uptake of OA-NLC by neutrophils was monitored by producing fluorescent-labelled OA-NLCs via the addition of rhodamine 800 (0.1 mg/mL) in lipid phase during OA-NLC preparation. For this, human neutrophils (1.8×10 7 cells/mL)
were labeled with Dil-C12 fluorescent dye. These labeled cells were co-incubated with labeled OA-NLC at 37°C for 5 min. The intracellular fluorescence signal was then observed and localized by confocal laser scanning microscopy (CLSM).
Determination of cytosolic Ca
2+
Isolated human neutrophils were suspended in HBSS containing Fluo 3-AM (2 μM; Molecular Probes, Eugene, OR) at a density of 3×10 6 cells/mL at 37°C for 30 min. The cells were then re-suspended in HBSS containing CaCl 2 (1 mM). The loaded cells were subsequently treated with vehicle, OA, or OA-NLC for 5 min, before undergoing stimulation with fMLF (0.1 μM). Intracellular free Ca 2+ measurements were conducted using a fluorescence spectrophotometer (Hitachi F-4500) at an excitation wavelength of 488 nm and an emission wavelength of 520 nm. The maximum and minimum fluorescence values were respectively obtained by adding 0.05% Triton X-100 and 20 mM ethylene glycol tetraacetic acid.
Induction of inflammatory responses in mice skin
LTB4, one of the most potent neutrophil chemotactic compounds, 21 was used to induce skin inflammation in our in-vivo mice model. For this, male BALB/c mice (8 weeks old; weighing 18-20 g) (Lasco, Taipei, Taiwan) were housed in a pathogen-free environment at Chang Gung University (CGU). OA (in ethanol) and OA-NLC (in ddH 2 O) were applied topically to both ear of the mice for a period of 30 min, followed by the topical application of LTB4 (0.5 μg/mL, in ethanol). One day after inducing inflammation, the mice were anaesthetized by inhalation of 1-2% isoflurane to obtain skin tissue samples (6 mm in diameter). All procedures performed on the animals were in accordance with protocols approved by the Institutional Animal Care and Use Committee of CGU. Notes: OA-NLC was applied to a copper grid coated with formvar/carbon film, and then stained with 1% phosphotungstic acid. The sample was subsequently dried in the air prior to observation under TEM. Scale bar, 200 nm. Representative data from four independent experiments are shown. Abbreviations: OA-NLC, oleic acid within nanostructured lipid carriers; TEM, transmission electron microscopy.
Skin histology and MPO assay
For histological analysis, the skin samples were fixed in 10% formalin, embedded in paraffin, sliced using a microtome at a thickness of 3 μm, mounted on glass slides, and then stained using hematoxylin and eosin (HE). The histological morphology of skin samples were observed using a microscope (Eclipse TS100; Nikon, Tokyo, Japan). MPO activity was used to indicate the infiltration of neutrophils. For this, skin samples were frozen in liquid nitrogen and stored at −70°C until MPO activity assays were performed. After thawing, the samples were immersed in phosphate buffer saline (PBS) containing hexadecyltrimethylammonium bromide (0.5%) before undergoing sonication and centrifugation. The homogenates were then suspended in PBS containing o-dianisidine hydrochloride (0.167 mg/mL) and hydrogen peroxide (0.0005%, Sigma). MPO activity was evaluated by spectrophotometric analysis to monitor changes in absorbance at 460 nm. Final MPO activity values were normalized to the corresponding protein concentration.
Statistical analysis
The data are presented as mean ± SEM. For statistical analysis, we performed Student's t-tests using SigmaPlot software (Systat Software, San Jose, CA).
In examining differences among groups, the p-value which were lower than 0.05 were considered significant.
Results
Characterization of NLC
The morphology, particle size, zeta potential, and drug EE values of NLC are presented in Figure 1 and Cytotoxic effect of OA and OA-NLC LDH is commonly used as a cell death marker, as it is released when the cell membrane is disrupted. Our results revealed that neither OA nor OA-NLC led to LDH release when they are co-incubated with neutrophils at a concentration of 1-30 μg/mL for 15 min in the presence or absence of BSA (Figure 2 ). This suggests that neither OA nor OA-NLC is cytotoxic in this study.
OA-NLC inhibits superoxide generation and elastase release in activated human neutrophils
To determine whether OA-NLC inhibits neutrophil inflammatory responses, we first investigated the effects of OA-NLC on superoxide and elastase release in fMLF-activated human neutrophils. In the absence of BSA, superoxide generation was reduced by both OA and OA-NLC (0.1-10 μg/mL) in a concentration-dependent manner, with IC 50 values of 0.72±0.07 μg/mL and 0.83±0.09 μg/mL, respectively. However, in the presence of BSA (0.1%), only OA-NLC presented inhibitory effects on superoxide generation, with an IC 50 value of 26.43±0.06 μg/mL (Figure 3) . Similar results were observed in elastase release assays. In the absence of BSA, OA and OA-NLC were both shown to inhibit fMLF-or LTB4-induced elastase release (Figures 4 and  5) . In fMLF-stimulation experiments, the IC 50 values of OA and OA-NLC were 0.23±0.03 μg/mL and 0.42 ±0.08 μg/mL, respectively. In LTB-4 stimulation experiments, the IC 50 values of OA and OA-NLC were 0.91 ±0.05 μg/mL and 0.61±0.09 μg/mL, respectively. In the ]i values in fMLF-activated neutrophils; however, they ]i to return to half of the peak value (t 1/2 ) in a concentrationdependent manner. In the presence of BSA, OA-NLC, but not OA, affected t 1/2 values in activated cells (Table 2, Figure 6 ).
NLC uptake by neutrophils
OA-NLC is known to affect neutrophil activities and intracellular Ca 2+ mobilization. We further investigated the interaction between nanoparticles and neutrophils. For this, we visualized the internalization of fluorescence-labeled OA-NLC by neutrophils under CLSM ( Figure 7 ). Five minutes after the coculturing of labeled neutrophils and OA-NLC, notable fluorescence signals were observed throughout the neutrophil cytoplasm. The cell membrane of neutrophils was stained with Dil-C12 and remained intact following the uptake of nanoparticles.
Interaction of albumin and NLC
Following the administration of nanoparticles in vivo, a variety of proteins bound to the surfaces of the nanoparticles, which resulted in the formation of distinct nanoparticle-protein complex. We further investigated the physicochemical properties of the produced complex. The average size of albumin-NLC complex was 421.72 ±0.83 nm following the addition of 5% BSA, which was 200 nm larger than that of pure NLC. Based on these measurements, we estimated that the average thickness of additional corona was estimated to be 200 nm ( Figure 8 , Table 1 ). The addition of 5% BSA also changed the zeta potential changes from −40.59 mV to −12.61 mV, indicating that the negative surface charge had been somewhat neutralized. Morphologic observation under TEM revealed that the nanoparticles were surrounded by a protein cloud, which is known as the "protein corona". The diameter of the complex with a protein corona appeared to be larger than the diameter of the NLC without a protein corona.
OA-NLC attenuates the severity of LTB4-induced skin inflammation
An LTB4-induced skin inflammation model was used in our study to evaluate the anti-inflammatory effects of topically administered OA-NLC. Inflammation in mouse skin was induced by topical administration of LTB4 (5 μL, 0.5 mg/ear). Skin samples were subjected to HE stain and an assay for MPO activity. We performed skin inflammation assessment on the following groups of mice: sham-operated mice treated with ethanol (5 μL, 10%), mice with LTB4-induced skin inflammation, mice with LTB4-induced skin inflammation pretreated with OA (in ethanol, 5 μL, 0.6 mg/ear), and mice with LTB4-induced skin inflammation pretreated with OA-NLC (in ddH 2 O, 5 μL, 0.6 mg/ear). As shown in Figure 9 , skin inflammation was characterized by epidermal neutrophil infiltration, which was alleviated by both OA-NLC and OA. The significant increase in MPO activity that we observed in inflamed skin is a quantitative indicator of neutrophil infiltration. Administration of topical OA-NLC or OA was found to suppress the increase in MPO activity. OA-NLC showed efficacy superior to that of OA in histology and MPO assay ( Figure 9E ).
Discussion
Human neutrophils play a critical role in innate immunity by destroying invading pathogens. Neutrophils in the blood stream and at sites of inflammation are in constant contact with fatty acids, which have been shown to have various modulating effects on neutrophils. 22 Our findings revealed that OA and other C18 USFAs, including linoleic acid (C18:2, n-6; LA) and α-linolenic acid (C18:3, n-3; αLA), significantly inhibited superoxide anion and elastase release in neutrophils activated with fMLF (Table S1 ). FAs are transported in the circulatory system in two forms: triacylglycerols or non-esterified FA. Due to the low ] i to return to half of the peak value (t 1/2 ). In the presence of albumin, only OA incorporated within NLC, but not free form of OA, reduced t 1/2 . Our results indicate that reduced neutrophil responses are strongly correlated with the attenuation of Ca 2+ mobilization. We therefore posit that the anti-neutrophil effects of OA-NLC are mediated by PMCA-associated Ca 2+ mobilization.
The physicochemical characteristics of OA-NLC were also evaluated. The size of NLCs produced in this study ranged from 178 to 276 nm, which is suitable for intravenous administration and percutaneous absorption. The NLCs presented a negatively charged surface resulting from the presence of anionic FAs. The high zeta potentials ( zeta j j >30 mV) is an indication of good physical stability with little risk of particle aggregation. 31, 32 TEM results also revealed that the particles are nearly spherical in shape. Cytotoxicity is a major concern in the development of colloidal nanocarriers. 33, 34 The biodegradable materials used in the assembly of NLCs in this study have been used in a variety of cosmetic products and pharmaceuticals. We can therefore assume that the NLCs are as safe. 35, 36 Nevertheless, the nano-scaled size of nanoparticles can potentially promote cellular uptake of themselves, which can result in excessive drug payload or cytotoxicity.
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Nanoparticles have also shown to induce mitochondriaassociated oxidative stress, therefore initiating cytochrome P450 enzyme activity and the mitochondrial respiratory chain. 34, [37] [38] [39] Our results show that OA-NLC does not induce superoxide generation or LDH release in human neutrophils. This is a clear indication that the OA-NLC formulations were non-cytotoxic and hence safe for therapeutic application. Topical therapy is often the mainstay and initial treatment for inflammation-associated dermatologic diseases characterized by neutrophil infiltration. Lipid-based drug delivery systems, such as NLC and SLN, have shown considerable promise in the cutaneous application of active ingredients that are difficult to transport via conventional formulations. 16, 40 Cutaneous application of NLC forms a monolayer of hydrophobic film, which has an occlusive effect and thus prevents water evaporation. This water contained in stratum corneum reduces intercellular packing of by enlarging the intercellular gaps. Moreover, lipid nanoparticles can also take the follicular penetration route. 41 All these promote the permeation and retention of encapsulated molecules in the deeper skin layers. 42, 43 In this study, we utilized an in vivo animal model of LTB4-induced skin inflammation to evaluate the therapeutic effects of topically administered OA-NLC. Our results demonstrate the efficacy of OA-NLC in reducing neutrophil infiltration and thereby in mediating the severity of inflammation. OA loaded in NLC can provide superior anti-inflammatory effect than that of free OA, indicating that NLC could promote the skin permeation and retention of OA in skin.
Conclusion
This paper reports on the incorporation of OA in anionic NLC to overcome the problem of albumin undermining the anti-neutrophil activities of OA. In the presence of albumin, only OA-NLC (ie, not free OA) was shown to inhibit superoxide generation and elastase release in fMLF-induced neutrophils by regulating Ca 2+ mobilization. The ability of topically applied OA-NLC to alleviate the severity of skin inflammation induced by LTB4 is an indication of the potential therapeutic effects of this FAnano delivery system. Furthermore, our findings indicate that OA and other USFAs incorporated in NLC play a dual role as an active ingredient and a liquid lipid matrix.
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